Components of Rabies Vaccines	Excipients Table Allergens Table Components Table
Indication Induction of active immunity against rabies virus, either before or after viral exposure Proprietary Name Imovax Rabies RabAvert Manufacturers sanofi pasteur Novartis Viability Inactivated Inactivated Microorganism Virus, genus Lyssavirus, family Rhabdoviridae Virus, genus Lyssavirus, family Rhabdoviridae Dose 1.0 mL 1.0 mL Route Intramuscular Intramuscular Dose form Powder Powder Appearance Creamy white to orange - After reconsitution, pink - red White, freeze-dried - After reconstitution, clear to slightly opaque, colorless suspension Concentration (per 1.0 mL) Rabies antigen, ≤ 2.5 IU Rabies antigen, ≤ 2.5 IU Preservatives None None Adjuvant None None Excipients Phenol red indicator, 20 mg Potassium glutamate, 1 mg Polygeline, 12 mg Human Serum Albumin, <0.3 mg Sodium EDTA, 0.3 mg Allergens Albumin, <100 mg Neomycin sulfate, < 150 mcg Neomycin, < 1 mcg Bovine gelatin (polygeline), < 12 mg Ovalbumin, < 3 ng Bovine serum used in cell culture process Chicken protein, trace amounts Chlortetracycline, < 20 ng Amphotericin B, < 2 ng Media Human diploid cells, MRC5 strain Synthetic cell culture medium with the addition of human albumin, polygeline, antibiotics Packaging Single dose vial with diluent and syringe/needle Single dose vial with diluent and syringe/needles Routine Storage 2 to 8° C (36-46° F) Do not freeze 2 to 8° C (36-46° F) Use immediately after reconstitution updated August 2005
This page was last updated on January 08, 2013 © 2005 Institute for Vaccine Safety